Scientific Communications
The Scientific Committee of the XVII Congreso de la Sociedad Española de Farmacia Industrial y Galénica invites you to actively participate by presenting a scientific communication.
Key dates:
- 1st July 2024 | Opening date for submissions
30th September 202414th October 2024| Closing of submission period- 30th October 2024 | Notification of acceptance of communications
For any information related to the submission of scientific communications, please contact us in comitecientifico@
How to submit your Scientific Communication?
- Create an account on the congress website by clicking on the following link.
- Once you have created your account, log in.
- Send the scientific communication through the “Send scientific communication” button. Attach the file with the last name and first name of the contact person followed by the title of the communication. For example: Gonzalez_Ana_Design_and_xxxx_xx_xx_xxxxx
NOTICE: Registration on the congress website does not imply registration for the congress, this must be done through the procedure provided for this purpose.
Guidelines for submitting communications
- Submissions must be written in English or Spanish, and must conform to the template prepared for this purpose.
- These should be sent exclusively by digital form (in PDF format) indicating the preferred mode of presentation (oral or poster).
- Papers should describe work that contains preliminary or completed results.
- The deadline for submission of papers is 30th September 2024 inclusive. Communications received later than the dates set by the scientific committee will not be accepted.
- It is not necessary to be registered for the congress in order to send papers, but it is necessary to be registered on the congress website.
- Within the submission form, the section in which the contribution is to be presented must be specified within the following categories: 3D printing; gene therapy, biological drugs, cell therapy and nanoparticles; pharmaceutical technology; biopharmaceutics and pharmacokinetics; clinical pharmacy; teaching; others.
- The communications received will be evaluated by the scientific committee, which will be responsible for admitting or rejecting the communications submitted and select the mode of presentation.
- It is essential that the first author is registered for the conference, attends the conference and defends the communication at the place and time indicated by the organisers. If this is not possible, he/she must designate a co-author for the presentation, and the latter will be obliged to register. If this is not done, the corresponding certificate accrediting the presentation of the paper will not be issued.